Stay updated on TGRX-326 Chinese Phase I Clinical Trial
Sign up to get notified when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.

Latest updates to the TGRX-326 Chinese Phase I Clinical Trial page
- Check2 days agoChange DetectedRecord History now shows a new entry for Revision v3.3.4, superseding v3.3.3. The update adds to the history log without visible changes to trial data on this view.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange Detected- Revision: v3.3.3 was added to the page history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer/release notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page history shows the addition of Revision: v3.3.2 and the removal of Revision: v3.2.0.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the government funding operating status notice from the page; the Record History and study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check80 days agoChange DetectedThe new screenshot shows a similar Record History page with minor styling/layout changes and no changes to study status or version history—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check102 days agoChange DetectedCore content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.SummaryDifference13%

Stay in the know with updates to TGRX-326 Chinese Phase I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.